Adage Capital Partners Gp, L.L.C. Immuno Gen, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $9.62 Million - $23.1 Million	771,928 Added 385.96%	971,928 $28.8 Million
Q3 2023 Nov 14, 2023	SELL	$14.09 - $19.87 $6.34 Million - $8.94 Million	-450,000 Reduced 69.23%	200,000 $3.17 Million
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $63.7 Million - $341 Million	-16,982,815 Reduced 96.31%	650,000 $12.3 Million
Q1 2023 May 15, 2023	BUY	$3.67 - $4.92 $23.9 Million - $32 Million	6,513,815 Added 58.58%	17,632,815 $67.7 Million
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $14.6 Million - $20.3 Million	3,219,000 Added 40.75%	11,119,000 $55.2 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $16.5 Million - $23.8 Million	-3,686,193 Reduced 31.82%	7,900,000 $37.8 Million
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $5.54 Million - $9.72 Million	1,300,000 Added 12.64%	11,586,193 $55.2 Million
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $12 Million - $19 Million	2,536,193 Added 32.73%	10,286,193 $76.3 Million
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $3.76 Million - $4.94 Million	750,000 Added 10.71%	7,750,000 $43.9 Million
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $14.5 Million - $21.5 Million	2,500,000 Added 55.56%	7,000,000 $46.1 Million
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $13.2 Million - $21.3 Million	2,025,000 Added 81.82%	4,500,000 $36.5 Million
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $9.16 Million - $19 Million	2,475,000 New	2,475,000 $16 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.